VERTEX PHARMACEUTICALS INC / MA: net_income
| Value | {"amount": -107032000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2012-01-01 – 2012-12-31 |
| Status | current |
| Entity | VERTEX PHARMACEUTICALS INC / MA |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:42:18.745941+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f2d1462d-5967-40e5-b129-c2780e8796a0
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000875320-13-000009Retrieved: 2026-08-19T08:42:18.745941+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000875320/net-income/2012-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f2d1462d-5967-40e5-b129-c2780e8796a0
History
- no predecessors — first report